Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
Study NCT ID:
NCT01652469
Status:
COMPLETED
Last Update Posted:
2022-08-24
First Post:
2012-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
ETOP3-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |